Prof.dr. Pieter Doevendans,

Medical Manager and Chairman

Prof.dr. Marc Vos,

Research and Education Manager

Robert van Barneveld MHA,

Healthcare Manager

Karin Krol-Simons RA,

Business Manager

The year 2013 at the Division of Heart & Lungs was marked mainly by investments in the future. Investments were made in the fields of patient care, research and education, as evidenced by the results outlined in this year end report. Investing in cutting-edge research allows us to build further on the progress we have already made by generating significant research results and eventually creating optimal treatments for our patients. Investment also means initiating and strengthening national and international collaborations because we can achieve more when we join forces. We invest in the care we give our patients by offering new treatments. We were granted JCI accreditation in 2013, which means that our organization meets international quality standards in the field of care, research and education. This was also an investment in the future, because quality is never a finished product - we can always improve.

At the Division of Heart & Lungs, we fulfill our ambitions together. This year end report shows that we have yet again set the bar a little higher this year. I hope that we can continue working together equally as motivated again next year.

Prof. Pieter Doevendans

Medical Manager and Chairman

Division of Heart & Lungs

medisch manager en voorzitter

Divisie Hart